Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lung cancer
lung cancer
First of its Kind “Universal” Immune Cell Cancer Therapy
Xtalks
Thu, 01/23/20 - 12:18 pm
cancer
immune system
prostate cancer
lung cancer
breast cancer
Cardiff University
BeiGene lung cancer treatment meets main goal in late-stage study
Reuters
Tue, 01/21/20 - 11:53 am
BeiGene
cancer
lung cancer
clinical trials
tislelizumab
The three biggest challenges in lung cancer, and how researchers are tackling them
Pharmaforum
Tue, 01/21/20 - 11:02 am
lung cancer
Lung Ambition Alliance
R&D
Bankrupt uBiome sells off patents, data for $7M; J&J buys options on Pulmatrix's lung cancer drugs
Endpoints
Fri, 01/3/20 - 10:08 am
uBiome
microbiome
M&A
Psomagen
JNJ
Pulmatrix
lung cancer
Spectrum Pharma Shares Slump After Lung-Cancer Drug Doesn't Meet Phase II Endpoint
TheStreet.com
Thu, 12/26/19 - 01:16 pm
Spectrum Pharma
lung cancer
clinical trials
poziotinib
non-small cell lung cancer
Upcoming events – Axsome’s depression data and Eli Lilly’s IL-10 in lung cancer
EP Vantage
Fri, 12/13/19 - 11:02 am
Axsome Therapeutics
AXS-05
treatment-resistant depression
depression
Eli Lilly
pegilodecakin
lung cancer
Regeneron defends bid to challenge Merck in lung cancer
Biopharma Dive
Tue, 11/5/19 - 11:45 pm
Regeneron
Libtayo
Merck
Keytruda
immuno-oncology
lung cancer
Should Merck Investors Worry About Bristol Myers' Lung Cancer Drug Results?
Motley Fool
Mon, 11/4/19 - 10:23 am
Merck
Bristol-Myers Squibb
Yervoy
Opdivo
Keytruda
lung cancer
Triple meeting – Mirati avoids the worst-case scenario
EP Vantage
Tue, 10/29/19 - 10:34 am
Mirati Therapeutics
MRTX849
lung cancer
colorectal cancer
Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful
Fierce Pharma
Mon, 10/7/19 - 12:18 pm
EGFR lung cancer
lung cancer
Eli Lilly
Cyramza
AstraZeneca
Tagrisso
Researchers Develop New Class of Lung Cancer Drugs
BioSpace
Thu, 09/19/19 - 12:15 pm
lung cancer
KRAS inhibitors
Institute of Cancer Research
drug development
Merck KGaA nabs FDA “Breakthrough” tag for MET-targeting lung cancer drug
Pharmaforum
Wed, 09/11/19 - 11:48 pm
FDA
Merck KGaA
MET
lung cancer
tepotinib
non-small cell lung cancer
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More
Xconomy
Mon, 09/9/19 - 08:08 pm
WCLC
lung cancer
KRAS
AMG 510
Amgen
RET
Merck
Keytruda
AstraZeneca
Imfinzi
Blueprint Medicines
Eli Lilly
Rova-T: the story of AbbVie’s multi-billion dollar failure
Pharmaforum
Wed, 09/4/19 - 10:12 am
AbbVie
lung cancer
M&A
Stemcentrx
Rova-T
Mylan's Newly-Approved Alimta Generic Will Not be Sold Until 2022
BioSpace
Mon, 09/2/19 - 12:25 pm
Eli Lilly
Mylan
Alimta
FDA
generics
lung cancer
3 Lung Cancer Stocks That Could Soar in September
Motley Fool
Mon, 08/5/19 - 12:04 am
lung cancer
Eli Lilly
Amgen
AstraZeneca
Amgen results beat estimates, lung cancer trial planned
Yahoo/Reuters
Wed, 07/31/19 - 08:49 am
Amgen
earnings
clinical trials
lung cancer
AMG510
AstraZeneca spearheads lung cancer alliance aiming to boost survival rates
Fierce Pharma
Mon, 07/22/19 - 10:04 am
lung cancer
AstraZeenca
Lung Ambition Alliance
Biodesix Looks to Become ‘the’ Lung Cancer Detection Co. With New Acquisition
Medical Devices and Diagnostics Industry
Fri, 06/28/19 - 11:54 pm
diagnostics
Biodesix
M&A
Oncimmune
lung cancer
Spotlight on: Exosome Diagnostics, first to develop RNA-based liquid biopsies
CP Wire
Wed, 06/5/19 - 07:28 pm
Exosome Diagnostics
diagnostics
Bio-Techne
prostate cancer
lung cancer
RNA
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »